Rodan & Fields, LLC finds itself as the defendant inanotherproposed class action lawsuit filed over alleged adverse side effects associated with its over-the-counter Lash Boost product. Filed in California, the lawsuit claims the isopropyl cloprostenate found in Lash Boost has been linked by the FDA to, among other ailments:
“Isopropyl cloprostenate is an active ingredient commonly found in medications used to treat glaucoma. Glaucoma is a disease involving high intraocular pressure, and isopropyl cloprostenate works to lower the intraocular pressure. Although this makes the drug effective for treating glaucoma, it can cause dangerous side effects in someone with normal eye pressure.”
Despite its FDA approval, isopropyl cloprostenate is not approved as a cosmetic additive, the lawsuit says, noting the plaintiff was supposedly unaware the compound was “actually a drug” with possible side effects. Per the plaintiff, the case claims the woman would have paid less for the defendant’s Lash Boost had she been aware of the possible side effects. To this point, the complaint indicates the defendant’s online representations of its Lash Boost product—“It is not a drug product and will not affect the structure and function of your lashes”—do consumers no favors in determining if they may experience any possible physical effects after using Lash Boost.